PODD Stock Analysis: Buy, Sell, or Hold?
PODD - Insulet Corporation
$207.04
-2.80 (-1.33%)
▼
5d:
-4.15%
30d:
-14.39%
90d:
-27.87%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
PODD is down 8.3% this week, but smart money is accumulating calls. Top strike: $260 2026-05-15 with 114 OI. Call ratio: 76% View Scanner →
Strength: 6.7/10
Get Alerted When PODD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PODD trading at deep discount. Market pricing in -13.7% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: PODD trading at deep discount. Market pricing in -13.7% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$393.41
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$244.27
15.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PODD is currently trading at $207.04, which is considered oversold relative to its 30-day fair value range of $218.40 to $244.86. From a valuation perspective, the stock is trading at a discount (Forward PE: 25.6) compared to its historical average (39.9). Remarkably, the market is currently pricing in an annual earnings decline of 13.7% over the next few years. This pessimistic expectation contrasts with the company's recent 3.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PODD is in a strong downtrend. The price is currently testing key support at $203.09. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $351.43 (+69.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PODD is in a strong downtrend. The price is currently testing key support at $203.09. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $351.43 (+69.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$218.40 -
$244.86
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 69.7% below Wall St target ($351.43)
Fair Price Analysis
30-Day Fair Range
$218.40 -
$244.86
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$203.09
Resistance Level
$232.18
Current Trend
Strong Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
25.62
Wall Street Target
$351.43
(+69.7%)
Revenue Growth (YoY)
31.2%
Earnings Growth (YoY)
3.9%
Profit Margin
9.1%
Valuation Discount vs History
-13.7% cheaper
PE vs Historical
25.6 vs 39.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.7%
(market-implied from PE analysis)
1-Year Target
$186.34
(-10%)
2-Year Target
$167.70
(-19%)
3-Year Target
$150.93
(-27%)
3-Yr Target (if PE normalizes)
(PE: 26→40)
$235.05
(+14%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 25.6, Growth: 27.3%)
$427.50
(+107%)
Base:
(SPY PE: 22.4, Growth: 27.3%)
$372.92
(+80%)
Bear:
(PE: 19.0, Growth: 27.3%)
$316.98
(+53%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (36x PE), but valuation improves significantly next year (26x PE) as earnings recover.
Forward PE: 36.23 | Forward EPS (Implied): $6.27
Bull Case
$274.20
(+21%)
Analyst growth 15.0%, PE expands to 38.0
Base Case
$227.08
(0%)
Market implied 0.0%, PE stable at 36.2
Bear Case
$173.72
(-24%)
Severe decline -15.0%, PE contracts to 32.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 25.6 to 39.9
Stabilization Target:
$322.42
(+55.7%)
PE Expansion Potential:
+55.7%
Share & Embed Analysis
Last updated: April 02, 2026 6:05 AM ET
Data refreshes hourly during market hours. Next update: 7:05 AM
Data refreshes hourly during market hours. Next update: 7:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PODD showing a specific setup today?
Insider Activity (6 Months)
2
Buys
1
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Michael R Minogue
BUY
2030 shares
2026-02-25
Ro Khanna
SELL
2026-02-24
Ro Khanna
BUY
2026-02-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 61 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 54 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
Advanced PODD Option Strategies
Professional options setups generated by AI based on today's PODD price and gamma walls.
